ClinicalTrials.Veeva

Menu

Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study

Stanford University logo

Stanford University

Status

Completed

Conditions

Head and Neck Cancers
Head and Neck Cancer

Treatments

Procedure: tumor biopsy

Study type

Observational

Funder types

Other

Identifiers

NCT00610415
SU-12142007-934 (Other Identifier)
ENT0023
98543 (Other Identifier)
NCT00610415
10514

Details and patient eligibility

About

To see if a limited sampling of tumor tissue from human subjects is a feasible way to gather adequate tissue for cancer stem cell quantification.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:1. Patients with malignant tumors seen at the Stanford University Cancer Center. Eligible patients will have a diagnosis of squamous cell carcinoma (HNSCC) and will have been seen in the Stanford Head and Neck Oncology Program. A decision to undergo surgery at Stanford will have been made, prior to recruiting patients for the study, and prior to obtaining the samples during surgery. (Histological confirmation of the diagnosis need not be made prior to obtaining consent.) 2. A definitive resection of a malignant tumor is planned. 3. Surgeon judgment that the definitive procedure will not be compromised by including

  • FNA
  • Core needle biopsy
  • Cup forceps or punch biopsy of<4mm. 4. Informed consent documented prior to procedure

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems